Therapeutic Drug Monitoring of Everolimus-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Everolimus

Published:2016-04 Issue:2 Volume:38 Page:143-169
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Shipkova Maria,Hesselink Dennis A.,Holt David W.,Billaud Eliane M.,van Gelder Teun,Kunicki Paweł K.,Brunet Mercè,Budde Klemens,Barten Markus J.,De Simone Paolo,Wieland Eberhard,López Olga Millán,Masuda Satohiro,Seger Christoph,Picard Nicolas,Oellerich Michael,Langman Loralie J.,Wallemacq Pierre,Morris Raymond G.,Thompson Carol,Marquet Pierre

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference223 articles.

1. . Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases.;Lebwohl;Ann N Y Acad Sci,2013

2. Clinical pharmacokinetics of everolimus.;Kirchner;Clin Pharmacokinet,2004

3. . Consensus document: therapeutic monitoring of tacrolimus (FK-506).;Jusko;Ther Drug Monit,1995

4. . Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.;Oellerich;Ther Drug Monit,1995

5. . Mycophenolate mofetil: a report of the consensus panel.;Shaw;Ther Drug Monit,1995

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway;Medicine;2024-08-09

3. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

4. Lack of Interchangeability Between 3 Different Methods for Quantification of Everolimus in Blood: ACMIA, LTIA, and UHPLC-MS/MS;Therapeutic Drug Monitoring;2024-07-31

5. Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation;Transplantation Direct;2024-06-20